MktsMarkets

MIRA Pharmaceuticals, Inc.
NASDAQ: MIRAKey statistics
MIRA News
Stories mentioning MIRA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 525.00 | 497.00 | 413.00 | 496.00 | 314.00 | 863.00 | 1,067 | 614.00 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 1,103 | 5,825 | 1,317 | 1,546 | 1,805 | 2,437 | 2,082 | 1,731 |
| Operating Income (Loss) | ||||||||
| Interest Income | ||||||||
| Interest Expense | (21.00) | (39.00) | (38.00) | (39.00) | ||||
| Other Expense | (47.00) | 0.00 | 21.00 | |||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (1,150) | (5,982) | (1,138) | (1,538) | (1,784) | (2,400) | (2,044) | (1,691) |
| Earnings Per Share (Basic) | (0.03) | (0.25) | (1.18) | (0.09) | (0.11) | (0.16) | (0.14) | (0.11) |
| Earnings Per Share (Diluted) | (0.03) | 0.03 | (1.18) | (0.09) | (0.11) | (0.16) | (0.14) | (0.11) |
| Weighted Average Shares Outstanding (Basic) | 41,941 | 23,694 | 19,275 | 16,986 | 16,645 | 15,444 | 15,072 | 14,781 |
| Weighted Average Shares Outstanding (Diluted) | 19,275 | 16,986 | 16,645 | 15,444 | 15,072 | 14,781 | ||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About MIRA
MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) is a stock listed on the Nasdaq Stock Market under the ticker symbol MIRA. It last traded at $0.6400 (Nov 17, 2026, 4:00 PM ET), up 1.4% on the day. That gives MIRA Pharmaceuticals a market capitalisation of $26.9M.
Over the past 52 weeks MIRA has traded between $0.5100 and $1.69.
For the quarter ended Mar 31, 2026 it reported a net loss of $1.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$1.2M |
| Dec 31, 2025 | — | -$6.0M |
| Sep 30, 2025 | — | -$1.1M |
| Jun 30, 2025 | — | -$1.5M |
From MIRA Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…